Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?MarketBeat • 05/28/26
HIMS vs. TEM: Which AI Healthcare Stock Offers Better Upside Now?Zacks Investment Research • 05/27/26
Hims & Hers faces steep climb to hit 2026 guidance as Wegovy churn risk looms, says BofAProactive Investors • 05/26/26
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending StockZacks Investment Research • 05/26/26
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform InvestmentBusiness Wire • 05/19/26
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform InvestmentBusiness Wire • 05/18/26
HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell?Zacks Investment Research • 05/15/26
BofA Cuts Hims & Hers Price Target as Mixed Quarter Resets Street Expectations24/7 Wall Street • 05/13/26
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?MarketBeat • 05/12/26